This CEO wants to cover weight loss drugs for employees. They're just too expensive.

For Dr. Joseph Cacchione, the math on GLP-1 drugs stopped making sense.

For Dr. Joseph Cacchione, the math on GLP-1 drugs stopped making sense.

Subscribe to read this story ad-free

Get unlimited access to ad-free articles and exclusive content.

The CEO of the Philadelphia-based nonprofit hospital system Jefferson said his organization now spends more on prescription drug coverage — fueled by the soaring use of weight loss medications like Wegovy and Zepbound — than it does on inpatient care.

Jefferson has dozens of hospitals across the region. It also has its own insurance plan for its 65,000 employees.